New Vic virus trial could hasten recovery

By Benita Kolovos
Updated August 8 2020 - 8:31am, first published 8:29am
Favipiravir was originally developed to treat people with influenza.
Favipiravir was originally developed to treat people with influenza.

Melbourne researchers are looking for people infected with COVID-19 to participate in a trial of an antiviral medication that could speed up their recovery.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options